canrenoic acid has been researched along with Body Weight in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (58.33) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collier, PS; Halliday, HL; Hawwa, AF; Kole, P; McElnay, JC; Millar, M; Millership, JS; Shields, MD; Suyagh, M | 1 |
| Andrew, R; Bistrup, C; Jensen, BL; McNeilly, AD; Ottosen, PD; Seckl, J; Skøtt, O; Thiesson, HC | 1 |
| Colombo Pirola, L; Russo, R; Schena, FP | 1 |
| Araki, T; Ino, H; Mabuchi, H; Shimizu, M; Takeda, R; Yoshio, H | 1 |
| Carloni, V; Foschi, M; Gentilini, P; La Villa, G; Laffi, G; Marra, F; Romanelli, RG | 1 |
| Funder, JW; Young, MJ | 1 |
| Altman, J; Gordan, P; Grünfeld, JP | 1 |
| Bräuninger, HJ; Gorbach, HC | 1 |
| Garcia del Rio, C; Haro, JM; Jodar, E; Soler, A; Vargas, F | 1 |
| Cachofeiro, V; Cañizo, FJ; Duran, F; Lahera, V; Rodriguez, FJ; Tresguerres, JA | 1 |
| Boer, P; Dorhout Mees, EJ; Hené, RJ; Koomans, HA | 1 |
| Armanini, D; Funder, JW; Goi, A; Karbowiak, I; Mantero, F | 1 |
2 trial(s) available for canrenoic acid and Body Weight
| Article | Year |
|---|---|
[Controlled clinical study on 2 antialdosterone diuretics in the nephrotic syndrome].
Topics: Adolescent; Adult; Aged; Blood Pressure; Body Weight; Canrenoic Acid; Clinical Trials as Topic; Diuresis; Female; Humans; Male; Middle Aged; Nephrotic Syndrome; Pregnadienes; Spironolactone | 1984 |
Torasemide in the treatment of patients with cirrhosis and ascites.
Topics: Adult; Aged; Ascites; Body Weight; Canrenoic Acid; Combined Modality Therapy; Diet, Sodium-Restricted; Diuretics; Female; Furosemide; Humans; Liver Cirrhosis; Male; Middle Aged; Natriuresis; Potassium; Sulfonamides; Torsemide | 1993 |
10 other study(ies) available for canrenoic acid and Body Weight
| Article | Year |
|---|---|
Potassium canrenoate treatment in paediatric patients: a population pharmacokinetic study using novel dried blood spot sampling.
Topics: Administration, Intravenous; Body Weight; Canrenoic Acid; Computer Simulation; Dried Blood Spot Testing; Drug Administration Schedule; Female; Gestational Age; Heart Failure; Humans; Infant; Infant, Newborn; Lung Diseases; Male; Prospective Studies; Treatment Outcome | 2013 |
Renal sodium retention in cirrhotic rats depends on glucocorticoid-mediated activation of mineralocorticoid receptor due to decreased renal 11beta-HSD-2 activity.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Animals; Atrial Natriuretic Factor; Bile Ducts; Blotting, Western; Body Weight; Canrenoic Acid; Dexamethasone; Epithelial Sodium Channels; Feces; Glucocorticoids; Kidney; Liver Cirrhosis; Male; Mineralocorticoid Receptor Antagonists; Nephrons; Nuclease Protection Assays; Organ Size; Potassium; Rats; Rats, Wistar; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Renin; Renin-Angiotensin System; Sodium | 2007 |
Effects of angiotensin-converting enzyme inhibitor and aldosterone antagonist on myocardial collagen in cardiomyopathic hamsters.
Topics: Aging; Animals; Body Weight; Canrenoic Acid; Captopril; Cardiomyopathies; Collagen; Cricetinae; Disease Models, Animal; Heart; Hydroxyproline; Male; Organ Size | 1995 |
The renin-angiotensin-aldosterone system in experimental mineralocorticoid-salt-induced cardiac fibrosis.
Topics: Aldosterone; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Body Weight; Canrenoic Acid; Cardiomegaly; Collagen; Corticosterone; Epithelium; Fibrosis; Heart; Imidazoles; Indoles; Losartan; Male; Myocardium; Nephrectomy; Organ Size; Perindopril; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Renin-Angiotensin System; Tetrazoles | 1996 |
[Effect of furosemide, potassium canrenoate and D-L-propranolol on blood pressure in spontaneously hypertensive rat].
Topics: Animals; Blood Pressure; Body Weight; Canrenoic Acid; Furosemide; Hypertension; Male; Models, Biological; Organ Size; Pregnadienes; Propranolol; Rats; Rats, Inbred Strains; Time Factors | 1976 |
[Clinical experience in the use of Osyrol 100 and Osyrol for injection (author's transl)].
Topics: Administration, Oral; Aged; Blood Pressure; Body Weight; Canrenoic Acid; Female; Heart Failure; Humans; Hyperaldosteronism; Injections; Liver Cirrhosis; Male; Natriuresis; Potassium; Pregnadienes; Sodium; Spironolactone | 1975 |
Effects of K+-canrenoate on the development of DOCA-salt hypertension.
Topics: Animals; Blood Pressure; Body Weight; Canrenoic Acid; Desoxycorticosterone; Heart Rate; Hypertension; Male; Natriuresis; Organ Size; Potassium; Pregnadienes; Rats; Rats, Inbred Strains; Time Factors | 1989 |
Acute effect of potassium canrenoate administration on renin-angiotensin, kallikrein-kinin and prostaglandin systems.
Topics: Animals; Blood Pressure; Body Weight; Canrenoic Acid; Diet; Diuresis; Injections, Intraperitoneal; Kallikreins; Kinins; Male; Potassium; Pregnadienes; Prostaglandins; Rats; Rats, Inbred Strains; Renin; Renin-Angiotensin System; Sodium; Sodium, Dietary | 1988 |
Adaptation to chronic potassium loading in normal man.
Topics: Acetazolamide; Adaptation, Biological; Administration, Oral; Adult; Aldosterone; Body Weight; Canrenoic Acid; Humans; Infusions, Parenteral; Injections, Intravenous; Kidney Tubules; Male; Potassium; Renin; Spironolactone; Time Factors | 1986 |
In-vivo metabolites of spironolactone and potassium canrenoate: determination of potential anti-androgenic activity by a mouse kidney cytosol receptor assay.
Topics: Animals; Body Weight; Canrenoic Acid; Cytosol; Kidney; Male; Mice; Orchiectomy; Organ Size; Pregnadienes; Receptors, Androgen; Seminal Vesicles; Spironolactone; Testosterone | 1985 |